+86-28-82633987
EN
CN EN

Syringaresinol

BP4760
487-35-4
98%
Phytopurify
(-)-Syringaresinol may be a potential chemotherapeutic agent for the treatment of cancer; it against H/R-induced cardiomyocyte injury and death, the degradation of HIF-1α through activation of FOXO3 is a potential therapeutic strategy for ischemia-related diseases. Syringaresinol induces vasorelaxation by enhancing NO production in endothelial cells via two distinct mechanisms, phosphatidylinositol 3-kinase/Akt- and PLC/Ca(2+)/CaMKKβ-dependent eNOS phosphorylation and Ca(2+)-dependent eNOS dimerization. Syringaresinol is a lignan that is 7,9':7',9-diepoxylignane substituted by hydroxy groups at positions 4 and 4' and methoxy groups at positions 3, 3', 5 and 5' respectively. It has a role as a plant metabolite. It is a lignan, a polyphenol, an aromatic ether, a polyether and a furofuran.
Catalog No Package Original Price Price Inventory Quantity Operating
BP4760-10mg 10mg $135.00
BP4760-20mg 20mg $230.00
BP4760-100mg 100mg $750.00
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

Syringaresinol Related Products

Product drug property prediction parameters

  • 95.8400

  • 2.5598

  • 2.5532

  • .0993

  • 7.3144

  • 4.2893

  • High

  • 89.5183

  • 3.7578

  • Yes

  • Yes

  • No

  • No

  • Yes

  • No

  • 0.0

  • Yes

  • No

  • No

  • No